Ditonno Francesco, Veccia Alessandro, Bignante Gabriele, Wu Zhenjie, Wang Linhui, Abdollah Firas, Stephens Alex, Simone Giuseppe, Tuderti Gabriele, Lee Randall, Eun Daniel D, Correa Andres F, De Cobelli Ottavio, Ferro Matteo, Porpiglia Francesco, Amparore Daniele, Checcucci Enrico, Tufano Antonio, Contieri Roberto, Perdonà Sisto, Bhanvadia Raj, Margulis Vitaly, Brönimann Stephan, Singla Nirmish, Porter James, Ghodoussipour Saum, Minervini Andrea, Mari Andrea, Lambertini Luca, Ghoreifi Alireza, Nativ Omri Falik, Gonzalgo Mark L, Sidhom Daniel, Sundaram Chandru P, Ben-David Reuben, Eraky Ahmed, Mehrazin Reza, Yoshida Takashi, Kinoshita Hidefumi, Dehghanmanshadi Alireza, Rais-Bahrami Soroush, Meagher Margaret F, Puri Dhruv, Derweesh Ithaar H, Moghaddam Farshad S, Djaladat Hooman, Bertolo Riccardo, Autorino Riccardo, Antonelli Alessandro
Department of Urology, Azienda Ospedaliera Universitaria Integrata Verona, University of Verona, Verona, 37126, Italy.
Department of Urology, Rush University, Chicago, IL, USA.
World J Urol. 2025 Sep 3;43(1):534. doi: 10.1007/s00345-025-05882-0.
Radical nephroureterectomy (RNU) for upper tract urothelial carcinoma (UTUC) in solitary kidney patients is a rare and underreported scenario. This study aims to compare the outcomes of UTUC solitary kidney patients becoming anephric after RNU to those of patients undergoing kidney-sparing surgery (KSS).
Data from patients with a solitary kidney were retrieved from the ROBUUST 2.0 database, a global, multicenter registry containing data on patients who underwent curative surgery for UTUC. Baseline patient demographics, disease characteristics, and surgical features were compared between RNU and KSS. Kaplan-Meier methods were used to estimate recurrence-free survival (RFS), metastasis-free survival (MFS), cancer-specific survival (CSS), and overall survival (OS) in patients undergoing RNU, with 3-year and 5-year cutoffs applied.
Thirty-nine patients (76.5%) underwent RNU, whereas 12 (23.5%) underwent KSS. Despite a comparable preoperative renal function, the distribution of CKD stages differed significantly between the groups (p = 0.019). Despite a similar rate of postoperative complications, patients undergoing RNU experienced a significantly higher median LOS (p < 0.001). Among RNU patients, OS was 83.9%, CSS was 96.9%, RFS was 71.8%, and MFS was 84.4% at the 3-year follow-up. After 5 years post-surgery, OS was 73.4%, CSS was 83.1%, RFS was 59.9%, and MFS was 78.5% in the same cohort.
UTUC solitary kidney patients undergoing RNU or KSS face a substantial perioperative burden. Despite these challenges, our cohort demonstrated favorable oncological outcomes comparable to those reported in the existing literature.
对于孤立肾患者的上尿路尿路上皮癌(UTUC)行根治性肾输尿管切除术(RNU)是一种罕见且报道不足的情况。本研究旨在比较UTUC孤立肾患者在RNU后成为无肾状态与接受保肾手术(KSS)患者的结局。
从ROBUUST 2.0数据库中检索孤立肾患者的数据,该数据库是一个全球多中心登记处,包含接受UTUC根治性手术患者的数据。比较RNU和KSS患者的基线人口统计学、疾病特征和手术特征。采用Kaplan-Meier方法估计接受RNU患者的无复发生存期(RFS)、无转移生存期(MFS)、癌症特异性生存期(CSS)和总生存期(OS),应用3年和5年的截断值。
39例患者(76.5%)接受了RNU,而12例(23.5%)接受了KSS。尽管术前肾功能相当,但两组间慢性肾脏病(CKD)分期分布差异显著(p = 0.019)。尽管术后并发症发生率相似,但接受RNU的患者中位住院时间显著更长(p < 0.001)。在RNU患者中,3年随访时OS为83.9%,CSS为96.9%,RFS为71.8%,MFS为84.4%。在同一队列中,术后5年时OS为73.4%,CSS为83.1%,RFS为59.9%,MFS为78.5%。
接受RNU或KSS的UTUC孤立肾患者面临着巨大的围手术期负担。尽管存在这些挑战,但我们的队列显示出与现有文献报道相当的良好肿瘤学结局。